{"id":"https://openalex.org/W3134577157","doi":"https://doi.org/10.3389/fimmu.2021.632399","title":"Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs","display_name":"Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs","publication_year":2021,"publication_date":"2021-03-05","ids":{"openalex":"https://openalex.org/W3134577157","doi":"https://doi.org/10.3389/fimmu.2021.632399","mag":"3134577157","pmid":"https://pubmed.ncbi.nlm.nih.gov/33746969","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7973099"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2021.632399","doi":"https://doi.org/10.3389/fimmu.2021.632399","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.632399","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.632399/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.632399/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057846465","display_name":"Criselle D\u2019Souza","orcid":"https://orcid.org/0000-0003-2257-6388","observed_orcids":["https://orcid.org/0000-0003-2257-6388"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Criselle D'Souza","raw_affiliation_strings":["Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031193094","display_name":"Henry Miles Prince","orcid":"https://orcid.org/0000-0002-0058-2448","observed_orcids":["https://orcid.org/0000-0002-0058-2448"]},"institutions":[{"id":"https://openalex.org/I1320473756","display_name":"The Royal Melbourne Hospital","ror":"https://ror.org/005bvs909","country_code":"AU","type":"funder","lineage":["https://openalex.org/I1320473756","https://openalex.org/I4210158168"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"H. Miles Prince","raw_affiliation_strings":["Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia","Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I1320473756","https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039295944","display_name":"Paul Joseph Neeson","orcid":"https://orcid.org/0000-0002-2729-5887","observed_orcids":["https://orcid.org/0000-0002-2729-5887"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Paul J. Neeson","raw_affiliation_strings":["Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I2800555584"]},{"raw_affiliation_string":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5039295944","https://openalex.org/A5057846465"],"corresponding_institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.8191,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.86638975,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"12","issue":null,"first_page":"632399","last_page":"632399"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.996999979019165},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.9390000104904175},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9020000100135803},{"id":"https://openalex.org/keywords/pomalidomide","display_name":"pomalidomide","score":1.0},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.8510000109672546},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8259999752044678},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9300000071525574},{"id":"https://openalex.org/keywords/th1-response","display_name":"Th1 response","score":0.871999979019165},{"id":"https://openalex.org/keywords/t-cell-receptor-ligation","display_name":"T cell receptor ligation","score":0.699999988079071},{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.8230000138282776},{"id":"https://openalex.org/keywords/elotuzumab","display_name":"elotuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9399999976158142},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9470000267028809},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5022256374359131},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4854791462421417},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32042908668518066}],"mesh":[{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D010950","descriptor_name":"Plasma Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3389/fimmu.2021.632399","doi":"https://doi.org/10.3389/fimmu.2021.632399","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.632399","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.632399/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7973099","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7973099","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:33746969","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33746969","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/277901","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11343/277901","pdf_url":"http://hdl.handle.net/11343/277901","source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f88e6273deaa414f85916b1332f05e0f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f88e6273deaa414f85916b1332f05e0f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 12 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2021.632399","doi":"https://doi.org/10.3389/fimmu.2021.632399","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2021.632399","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2021.632399/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3134577157.pdf","grobid_xml":"https://content.openalex.org/works/W3134577157.grobid-xml"},"referenced_works_count":83,"referenced_works":["https://openalex.org/W267212056","https://openalex.org/W1571796034","https://openalex.org/W1893078101","https://openalex.org/W1955732360","https://openalex.org/W1969848086","https://openalex.org/W1994169908","https://openalex.org/W1995120586","https://openalex.org/W1995669533","https://openalex.org/W1996445917","https://openalex.org/W1999088487","https://openalex.org/W1999140904","https://openalex.org/W2006745473","https://openalex.org/W2007108179","https://openalex.org/W2012959199","https://openalex.org/W2015345028","https://openalex.org/W2025656486","https://openalex.org/W2033671876","https://openalex.org/W2049005444","https://openalex.org/W2049270621","https://openalex.org/W2059873406","https://openalex.org/W2063827408","https://openalex.org/W2066700805","https://openalex.org/W2083426483","https://openalex.org/W2085522503","https://openalex.org/W2086437355","https://openalex.org/W2088515900","https://openalex.org/W2104483573","https://openalex.org/W2104494161","https://openalex.org/W2110544227","https://openalex.org/W2113261463","https://openalex.org/W2115619738","https://openalex.org/W2116549767","https://openalex.org/W2117887415","https://openalex.org/W2118447882","https://openalex.org/W2119810076","https://openalex.org/W2120316083","https://openalex.org/W2120539841","https://openalex.org/W2125559109","https://openalex.org/W2131729321","https://openalex.org/W2132258376","https://openalex.org/W2133739087","https://openalex.org/W2133986577","https://openalex.org/W2135915916","https://openalex.org/W2137017500","https://openalex.org/W2162559503","https://openalex.org/W2163060468","https://openalex.org/W2171132738","https://openalex.org/W2187343014","https://openalex.org/W2207976342","https://openalex.org/W2316160054","https://openalex.org/W2411367252","https://openalex.org/W2476500971","https://openalex.org/W2507710513","https://openalex.org/W2510398184","https://openalex.org/W2528329272","https://openalex.org/W2548238752","https://openalex.org/W2576439044","https://openalex.org/W2612593950","https://openalex.org/W2625253716","https://openalex.org/W2688500010","https://openalex.org/W2761321056","https://openalex.org/W2767658830","https://openalex.org/W2770457793","https://openalex.org/W2771543204","https://openalex.org/W2801940994","https://openalex.org/W2890382682","https://openalex.org/W2891958511","https://openalex.org/W2892110441","https://openalex.org/W2900068404","https://openalex.org/W2900380139","https://openalex.org/W2912207391","https://openalex.org/W2914030177","https://openalex.org/W2952246870","https://openalex.org/W2955507058","https://openalex.org/W2968494115","https://openalex.org/W2988470278","https://openalex.org/W2988984460","https://openalex.org/W3010457103","https://openalex.org/W3011080606","https://openalex.org/W3017098331","https://openalex.org/W3036402047","https://openalex.org/W3095352143","https://openalex.org/W4313376856"],"related_works":["https://openalex.org/W2133739087","https://openalex.org/W1964981758","https://openalex.org/W295087915","https://openalex.org/W3082995442","https://openalex.org/W2116549767","https://openalex.org/W2982499850","https://openalex.org/W2001938938","https://openalex.org/W2507526053","https://openalex.org/W2135404380","https://openalex.org/W1741438581"],"abstract_inverted_index":{"Immunomodulatory":[0],"drugs":[1,128],"(IMiDs)":[2],"are":[3],"effective":[4],"treatments":[5],"for":[6,135,149],"patients":[7],"with":[8,131],"multiple":[9],"myeloma.":[10],"IMiDs":[11,58,75,132],"have":[12],"pleotropic":[13],"effects":[14,119,156],"including":[15],"targeting":[16],"the":[17,23,28,51,111,116,136,147,153],"myeloma":[18,31,127],"cells":[19,151],"directly,":[20],"and":[21,34,42,65,76,83,100,106],"improving":[22],"anti-myeloma":[24,138,155],"immune":[25,117],"response.":[26],"In":[27,50],"absence":[29],"of":[30,40,45,53,74,120,126,146,157],"cells,":[32],"lenalidomide":[33],"pomalidomide":[35],"induce":[36],"CD4+T":[37],"cell":[38,55,61,91,102,108],"secretion":[39],"IL-2":[41],"indirect":[43],"activation":[44],"Natural":[46],"Killer":[47],"(NK)":[48],"cells.":[49],"context":[52],"T":[54,60,90,99,107,150],"receptor":[56],"ligation,":[57],"enhance":[59],"proliferation,":[62],"cytokine":[63],"release":[64],"Th1":[66],"responses,":[67],"bothin":[68],"vivoandin":[69],"vitro.":[70],"Furthermore,":[71],"combination":[72,130],"treatment":[73],"myeloma-targeting":[77],"monoclonal":[78],"antibodies":[79],"eg.":[80],"daratumumab":[81],"(anti-CD38)":[82],"elotuzumab":[84],"(anti-SLAMF7),":[85],"checkpoint":[86],"inhibitors,":[87],"or":[88],"bispecific":[89],"engagers":[92],"showed":[93],"synergistic":[94],"effects,":[95],"mainly":[96],"via":[97],"enhanced":[98],"NK":[101],"dependent":[103],"cellular":[104],"toxicity":[105],"proliferation.":[109],"Conversely,":[110],"corticosteroid":[112],"dexamethasone":[113],"can":[114],"impair":[115],"modulatory":[118],"IMiDs,":[121],"indicating":[122],"that":[123],"careful":[124],"choice":[125],"in":[129,152],"is":[133],"key":[134],"best":[137],"therapeutic":[139],"efficacy.":[140],"This":[141],"review":[142],"presents":[143],"an":[144],"overview":[145],"role":[148],"overall":[154],"immunomodulatory":[158],"drugs.":[159]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":15},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2021-03-15T00:00:00"}